BioRad.io

Synthetic biology is the design, testing, and construction of new, standardized biological parts and devices, and programming them to do something productive. Significant medical breakthroughs are already happening as a result of advances in synthetic biology. From antiviral treatment and immune cell engineering to biomonitoring, the applications of synthetic biology are endless, creating new opportunities for innovative informatics. In this episode, we discuss revolutionary applications of synthetic biology in biopharma.

Guest: Mark Charbonneau, PhD, Director and Head of Quantitative Biology, Synlogic

Technologies for therapeutic antibody R&D have evolved rapidly, but the informatics needed to support these processes have struggled to keep up. In this episode, we discuss challenges in antibody discovery and benefits of improved informatics.

Data liquidity, the ability of data to flow easily and securely, provides tremendous value for biopharma researchers. Open access is paving the way for increased collaboration and discovery. However, additional initiatives are needed to further promote the management and sharing of scientific data and ensure that information is quickly available to researchers. This episode highlights the needs, solutions, and challenges of ensuring interoperability of research data throughout the data lifecycle.

Increasingly, pharma is looking at partnerships and collaborations to increase the velocity of drug discovery and development. Common data sharing platforms are not built to meet lab-specific requirements. In addition to discussing the necessity of simple and secure collaboration, listeners will learn about the dangers of not using proper tools.